Contact: Kathryn St. John (202) 249-6513  

WASHINGTON (Jan. 9, 2013) - The following statement can be attributed to Steven G. Hentges, Ph.D., of the Polycarbonate/BPA Global Group, American Chemistry Council (ACC), regarding an analysis of national survey data published in an online issue of "Kidney International":

"This study is inherently and fundamentally limited due to its reliance on single BPA exposure samples collected after the development of health effects. This type of analysis is incapable of establishing any meaningful connection between BPA and any chronic disease because it cannot establish any cause-and-effect relationship.

"The authors themselves state that: 'our cross-sectional study cannot definitely confirm that BPA contributes to heart disease or kidney dysfunction in children,' and they note the need for further research. Importantly, the study did not actually measure any effects on the heart or kidneys but only speculates about such effects. As stated by the authors: '[the] pediatric patients in our study had no demonstrable evidence of CKD [chronic kidney disease]'.

"More relevant to actual, real-world safety is the recent, robust research funded by the Environmental Protection Agency and conducted by scientists at the government's Pacific Northwest National Laboratory, Centers for Disease Control and Prevention, and Food and Drug Administration. Consistent with previous human and animal studies, the Pacific Northwest study (Teeguarden et al.) indicates that, because of the way BPA is processed in the body, it is very unlikely that BPA could cause health effects at any realistic exposure level. Furthermore, regulators from Europe to Japan to the United States have recently reviewed hundreds of studies on BPA and repeatedly supported the continued safe use of BPA."

Polycarbonate/BPA Global Group of ACC  |  Facts About BPA |


News & Resources

View our resource center to find press releases, testimonies, infographics and more.